Clinical Trial Update: A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 clinical trial to study PF-08049820 in people with atopic dermatitis (eczema); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-08049820

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis, Eczema, Atopic | Phase 2 | Status: ACTIVE_NOT_RECRUITING